rs775696136
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001369.3(DNAH5):βc.13458_13459insTβ(p.Asn4487Ter) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00016 in 1,613,806 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.000092 ( 0 hom., cov: 32)
Exomes π: 0.00017 ( 0 hom. )
Consequence
DNAH5
NM_001369.3 frameshift
NM_001369.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.69
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-13701316-T-TA is Pathogenic according to our data. Variant chr5-13701316-T-TA is described in ClinVar as [Likely_pathogenic]. Clinvar id is 350995.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH5 | NM_001369.3 | c.13458_13459insT | p.Asn4487Ter | frameshift_variant | 77/79 | ENST00000265104.5 | NP_001360.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH5 | ENST00000265104.5 | c.13458_13459insT | p.Asn4487Ter | frameshift_variant | 77/79 | 1 | NM_001369.3 | ENSP00000265104 | P4 | |
DNAH5 | ENST00000681290.1 | c.13413_13414insT | p.Asn4472Ter | frameshift_variant | 77/79 | ENSP00000505288 | A1 | |||
DNAH5 | ENST00000683611.1 | n.791_792insT | non_coding_transcript_exon_variant | 3/5 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 151966Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
14
AN:
151966
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251312Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135840
GnomAD3 exomes
AF:
AC:
16
AN:
251312
Hom.:
AF XY:
AC XY:
9
AN XY:
135840
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000168 AC: 245AN: 1461840Hom.: 0 Cov.: 34 AF XY: 0.000175 AC XY: 127AN XY: 727226
GnomAD4 exome
AF:
AC:
245
AN:
1461840
Hom.:
Cov.:
34
AF XY:
AC XY:
127
AN XY:
727226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000921 AC: 14AN: 151966Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74214
GnomAD4 genome
AF:
AC:
14
AN:
151966
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74214
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:6
Likely pathogenic, criteria provided, single submitter | clinical testing | UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill | Nov 08, 2018 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | The c.13458dupT (p.Asn4487Ter) variant results in a frameshift, and is predicted to result in premature termination of the protein. The p.Asn4487Ter variant has been reported in one patient with primary ciliary dyskinesia in a homozygous state, and three patients in a compound heterozygous state with a second missense or frameshift variant (Hornef et al. 2006). Control data are unavailable for this variant, which is reported at a frequency of 0.00070 in the African American population of the Exome Sequencing Project. Based on the evidence and the potential impact of frameshift variants, the p.Asn4487Ter variant is classified as likely pathogenic for primary ciliary dyskinesia. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 15, 2023 | This sequence change creates a premature translational stop signal (p.Asn4487*) in the DNAH5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAH5 are known to be pathogenic (PMID: 11788826, 16627867). This variant is present in population databases (rs775696136, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with primary ciliary dyskinesia (PMID: 16627867, 21270641). ClinVar contains an entry for this variant (Variation ID: 350995). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | research | Centre for Genomic and Experimental Medicine, University of Edinburgh | Apr 01, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 19, 2020 | The c.13458dupT pathogenic mutation (also known as p.N4487* and c.13458_13459insT), located in coding exon 77 of the DNAH5 gene, results from a duplication of T at nucleotide position 13458. This changes the amino acid from an asparagine to a stop codon within coding exon 77. This alteration was first identified in 4 families with PCD; it was detected in conjunction with another pathogenic mutation in 3 families and in the homozygous state in 1 family (Hornef N et al. Am. J. Respir. Crit. Care Med. 2006; 174:120-6). This alteration was also identified in conjunction with a deletion of exon 62 in a 16 year old female with PCD; this individual had a history of neonatal respiratory distress, situs inversus, bronchiectasis, sinusitis, frequent otitis media, significantly reduced nasal nitric oxide, and outer dyenin arm defects on electron microscopy (Berg JS et al. Genet. Med. 2011; 13:218-29). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Primary ciliary dyskinesia 3 Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Dec 18, 2019 | This DNAH5 variant (rs775696136) has been identified in the homozgyous or compound heterozgygous state in multiple patients with primary ciliary dyskinesia. It is rare in population datasets (gnomAD: 16/251312 total alleles; 0.006367%; no homozygotes). Two submitters to ClinVar have classified DNAH5 c.13458dupT as either likely pathogenic or pathogenic. This frameshift variant results in a premature stop codon in exon 77 of 79 likely leading to nonsense-mediated decay and lack of protein production. We consider this variant to be pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Genomics England Pilot Project, Genomics England | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 25, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Feb 02, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Primary ciliary dyskinesia 3 (MIM#608644). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2; 16 heterozygotes, 0 homozygotes). (SP) 0701 - Other variants predicted to result in NMD comparable to the one identified in this case have very strong previous evidence for pathogenicity (ClinVar, DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been reported in multiple individuals with primary ciliary dyskinesia, both homozygotes and compound heterozygotes (ClinVar, PMID: 33635012). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 20, 2021 | The DNAH5 c.13458dupT; p.Asn4487Ter variant (rs775696136) is reported in the literature in the homozygous or compound heterozygous state in nine individuals affected with primary ciliary dyskinesia (Hornef 2006, Fassad 2020). This variant is also reported in ClinVar (Variation ID: 350995). This variant is found in the non-Finnish European population with an overall allele frequency of 0.01% (13/113666 alleles) in the Genome Aggregation Database. This variant results in an early termination codon and is predicted to results in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Hornef N et al. DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. Am J Respir Crit Care Med. 2006 Jul 15;174(2):120-6. PMID: 16627867. Fassad MR et al. Clinical utility of NGS diagnosis and disease stratification in a multiethnic primary ciliary dyskinesia cohort. J Med Genet. 2020 May;57(5):322-330. PMID: 31879361. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Jul 13, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 26, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31638833, 34791246, 34758253, 24498942, 31980526, 31589614, 33635012, 35753512, 21270641, 30293990, 16627867, 31879361) - |
DNAH5-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 21, 2024 | The DNAH5 c.13458dupT variant is predicted to result in premature protein termination (p.Asn4487*). This variant has been reported in the homozygous or compound heterozygous state in individuals with primary ciliary dyskinesia (see, for example, Hornef et al. 2006. PubMed ID: 16627867; Quinlan-Jones et al. 2018. PubMed ID: 30293990; Fassad et al. 2019. PubMed ID: 31879361). This variant is reported in 0.012% of alleles in individuals of African descent in gnomAD. Nonsense variants in DNAH5 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at